Patient Drug Prices To Drop In Australia Under New Pharmacy Oversight
This article was originally published in PharmAsia News
Executive Summary
Australia's new pharmaceutical price-disclosure policy taking effect Aug. 1 is expected to lead to U.S.$18 million in savings to patients, some prices dropping but as much as $15 per prescription.
Australia's new pharmaceutical price-disclosure policy taking effect Aug. 1 is expected to lead to $18 million in savings to patients, some prices dropping but as much as $15 per prescription. The pricing policy investigates price differences among pharmacies dispensing government-subsidized drugs and forces down the excessive ones. The moves are expected to lower the cost of the anti-cholesterol drug, simvastatin, by as much as $10 a prescription, the health ministry said. (Click here for more)
"Patients To Save Up To $120 A Year As Prescription Medicine Prices Tumble" - Perth Now (Australia) (7/31/2013)